Skip to main content

Table 1 IC 50 values for ferroquine (FQ), hydroxyl-ferroquine (FQ-OH), ruthenoquine (RQ), chloroquine (CQ) and mefloquine (MQ) in non-cancerous MRC-5 and HeLa cancer cells

From: In vitro and in vivo antischistosomal activity of ferroquine derivatives

Complex

IC50MRC-5 (µM)

IC50HeLa (µM)

Cisplatin

7.9  ± 1.2

11.5  ± 2.9

FQ

24.4  ± 0.9

10.1  ± 0.3

FQ-OH

22.6  ± 1.2

16.8  ± 1.5

RQ

21.9  ± 2.6

8.8  ± 0.41

CQ

55.1  ± 1.3

87.0  ± 1.5

MQ

16.7  ± 0.2

6.7  ± 0.7

  1. Cisplatin was used as positive control. Standard deviations are shown in superscript.